OCA
DXCM icon

Octagon Capital Advisors’s DexCom DXCM Stock Holding History

Octagon Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,000
Closed -$1.7M – 37
2022
Q4 		$1.7M Sell
15,000
-25,000
-63% -$2.74M 0.26% 27
2022
Q3 		$3.22M Buy
+40,000
New +$3.39M 0.56% 27

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Octagon Capital Advisors's DXCM Position: Q1 2023 in Review

Octagon Capital Advisors sold out of DexCom (DXCM) in Q1 2023, closing a stake of 15,000 shares — an estimated $1.7M sold.

Octagon Capital Advisors first reported a position in DXCM in Q3 2022 and held it in 2 quarters. The position peaked at $3.22M in Q3 2022. 904 funds tracked by Wall St. Rank hold DXCM as of Q1 2023.

  • Octagon Capital Advisors reported no remaining DexCom position as of Q1 2023 after selling out during the quarter.
  • Octagon Capital Advisors sold 15,000 DexCom shares in Q1 2023, an estimated $1.7M.
  • Octagon Capital Advisors first reported a position in DexCom in Q3 2022 and held it in 2 quarters.
  • Octagon Capital Advisors's DexCom position peaked at $3.22M in Q3 2022.
  • 904 funds tracked by Wall St. Rank held DexCom as of Q1 2023.

Based on Octagon Capital Advisors's 13F filing for Q1 2023, filed 15 May 2023.